Search research articles
Contact Us
Filters
Showing results (221-230 of 293) with videos related to
Page
of 30
Sort By:
Nature Communications
|
April 29, 2025
AI-driven discovery of synergistic drug combinations against pancreatic cancer
Mohsen Pourmousa, Sankalp Jain, Elena Barnaeva, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
June 14, 2023
Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro
Alec T Salminen, Kelly J Davis, Robert P Felton, et al.
Scientific Reports
|
December 12, 2018
DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation
Camilo Rojas, Elena Barnaeva, Ajit G Thomas, et al.
Assay and Drug Development Technologies
|
April 20, 2004
A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format
Norbert T Peekhaus, Marc Ferrer, Tina Chang, et al.
ACS Combinatorial Science
|
September 3, 2015
High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors
Shanshan He, Prashi Jain, Billy Lin, et al.
Science Advances
|
March 5, 2020
Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models
Lu Yu, Xiaoli Zhang, Yexin Yang, et al.
Journal of Medicinal Chemistry
|
December 24, 2004
A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists
Jeffrey J Hale, Christopher L Lynch, William Neway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2017
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma
Christine M Heske, Mindy I Davis, Joshua T Baumgart, et al.
Biorxiv : the Preprint Server for Biology
|
May 20, 2021
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
Hoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, et al.
Molecular Pharmacology
|
August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding Sites
Kathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 293) with videos related to
Sort By:
Page
of 30
Nature Communications
|
April 29, 2025
AI-driven discovery of synergistic drug combinations against pancreatic cancer
Mohsen Pourmousa, Sankalp Jain, Elena Barnaeva, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
June 14, 2023
Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro
Alec T Salminen, Kelly J Davis, Robert P Felton, et al.
Scientific Reports
|
December 12, 2018
DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation
Camilo Rojas, Elena Barnaeva, Ajit G Thomas, et al.
Assay and Drug Development Technologies
|
April 20, 2004
A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format
Norbert T Peekhaus, Marc Ferrer, Tina Chang, et al.
ACS Combinatorial Science
|
September 3, 2015
High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors
Shanshan He, Prashi Jain, Billy Lin, et al.
Science Advances
|
March 5, 2020
Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models
Lu Yu, Xiaoli Zhang, Yexin Yang, et al.
Journal of Medicinal Chemistry
|
December 24, 2004
A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists
Jeffrey J Hale, Christopher L Lynch, William Neway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2017
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma
Christine M Heske, Mindy I Davis, Joshua T Baumgart, et al.
Biorxiv : the Preprint Server for Biology
|
May 20, 2021
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
Hoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, et al.
Molecular Pharmacology
|
August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding Sites
Kathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Page
of 30